As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment

A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.